A detailed history of First National Bank Of Omaha transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, First National Bank Of Omaha holds 51,986 shares of EW stock, worth $3.44 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
51,986
Previous 59,842 13.13%
Holding current value
$3.44 Million
Previous $5.72 Million 16.04%
% of portfolio
0.33%
Previous 0.37%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$84.3 - $94.31 $662,260 - $740,899
-7,856 Reduced 13.13%
51,986 $4.8 Million
Q1 2024

May 10, 2024

SELL
$72.54 - $95.56 $285,009 - $375,455
-3,929 Reduced 6.16%
59,842 $5.72 Million
Q4 2023

Feb 13, 2024

SELL
$61.71 - $77.76 $599,265 - $755,127
-9,711 Reduced 13.22%
63,771 $4.86 Million
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $642,987 - $866,659
-9,281 Reduced 11.21%
73,482 $5.09 Million
Q2 2023

Aug 14, 2023

BUY
$81.41 - $94.33 $2.2 Million - $2.55 Million
27,038 Added 48.52%
82,763 $7.81 Million
Q1 2023

May 03, 2023

SELL
$74.26 - $84.51 $148,074 - $168,512
-1,994 Reduced 3.45%
55,725 $4.61 Million
Q4 2022

Feb 08, 2023

SELL
$68.3 - $87.44 $196,635 - $251,739
-2,879 Reduced 4.75%
57,719 $4.31 Million
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $206,089 - $268,439
-2,502 Reduced 3.97%
60,598 $5.01 Million
Q2 2022

Sep 06, 2022

SELL
$86.5 - $128.27 $187,705 - $278,345
-2,170 Reduced 3.32%
63,100 $6 Million
Q1 2022

May 25, 2022

SELL
$101.96 - $128.34 $226,147 - $284,658
-2,218 Reduced 3.29%
65,270 $7.68 Million
Q4 2021

Feb 11, 2022

SELL
$106.37 - $130.68 $276,987 - $340,290
-2,604 Reduced 3.72%
67,488 $8.74 Million
Q3 2021

Nov 12, 2021

SELL
$102.91 - $122.75 $1.82 Million - $2.17 Million
-17,671 Reduced 20.13%
70,092 $7.94 Million
Q1 2021

May 06, 2021

BUY
$78.68 - $90.67 $1.25 Million - $1.45 Million
15,938 Added 22.19%
87,763 $7.34 Million
Q4 2020

Feb 18, 2021

SELL
$71.69 - $91.23 $2,007 - $2,554
-28 Reduced 0.04%
71,825 $6.55 Million
Q3 2020

Nov 06, 2020

SELL
$67.19 - $87.44 $57,245 - $74,498
-852 Reduced 1.17%
71,853 $5.74 Million
Q2 2020

Aug 05, 2020

BUY
$57.54 - $76.95 $2.79 Million - $3.73 Million
48,415 Added 199.32%
72,705 $5.02 Million
Q1 2020

Apr 29, 2020

SELL
$52.41 - $81.0 $20,754 - $32,076
-396 Reduced 1.6%
24,290 $4.58 Million
Q4 2019

Jan 17, 2020

SELL
$71.7 - $82.09 $147,773 - $169,187
-2,061 Reduced 7.71%
24,686 $5.76 Million
Q3 2019

Nov 04, 2019

SELL
$61.55 - $75.43 $452,023 - $553,957
-7,344 Reduced 21.54%
26,747 $5.88 Million
Q2 2019

Jul 10, 2019

SELL
$55.74 - $64.41 $178,925 - $206,756
-3,210 Reduced 8.61%
34,091 $6.3 Million
Q1 2019

May 01, 2019

SELL
$47.89 - $64.05 $5,363 - $7,173
-112 Reduced 0.3%
37,301 $7.14 Million
Q4 2018

Jan 23, 2019

BUY
$46.41 - $56.94 $1.74 Million - $2.13 Million
37,413 New
37,413 $5.73 Million
Q4 2018

Jan 22, 2019

SELL
$46.41 - $56.94 $1.8 Million - $2.21 Million
-38,756 Closed
0 $0
Q3 2018

Nov 05, 2018

SELL
$45.7 - $58.03 $26,003 - $33,019
-569 Reduced 1.45%
38,756 $6.75 Million
Q2 2018

Jul 12, 2018

SELL
$42.45 - $51.3 $4,287 - $5,181
-101 Reduced 0.26%
39,325 $5.73 Million
Q1 2018

May 03, 2018

SELL
$37.19 - $47.45 $215,850 - $275,399
-5,804 Reduced 12.83%
39,426 $5.5 Million
Q4 2017

Feb 05, 2018

BUY
$33.79 - $39.39 $1.53 Million - $1.78 Million
45,230
45,230 $5.1 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track First National Bank Of Omaha Portfolio

Follow First National Bank Of Omaha and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Bank Of Omaha, based on Form 13F filings with the SEC.

News

Stay updated on First National Bank Of Omaha with notifications on news.